症例報告②

Sun. May 26, 2024 1:30 PM - 2:30 PM JSNP/JSCNP Poster Session Hall

Chair: Toru Horinochi

+Add all to schedule

[JP11-1] Guanfacine as a Treatment for Borderline Personality Disorder: Two Case Reports

*Hiroaki Mori^1,2, Shinichiro Ochi¹, Hidetoshi Hashida², Jun-Ichi Iga¹, Shu-Ichi Ueno¹ (1. Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan., 2. Department of Neuropsychiatry, Shokokai Imabari Hospital, Takaichi 786-13, Imabari, Ehime, Japan.)

[JP11-2] Recovery of cognitive function through employment support for schizophrenia.

*Shusaku Fukutake¹, Yuka Takai¹, Eri Nakaoka¹, Soichiro Sato¹, Mitsuru Hikiji¹ (1. Social Medical Corporaition Takami Tokufuukai Kibougaoka Hospital)

[JP11-3] A case of rhabdomyolysis after over doses of risperidone.

Jun Takahashi¹, Kota Kikuchi¹, Yasushi Kawamata¹, *Norio Furukori¹ (1. Department of Psychiatry, Dokkyo Medical University School of Medicine)

[JP11-4] A case of depression treated with lamotrigine due to complications of cerebral vasospasm syndrome

*Keiichirou Nakae¹, Nahoko Watanabe¹, Chiaki Hashimoto¹, Taisei Yamashita¹, Minoru Urata¹, Mayo Kotani¹, Yuki Aoshika², Hitoshi Sakurai¹, Takashi Tsuboi¹, koichiro Watanabe¹ (1. Kyorin University Faculty of Medicine Psychiatry and neurology, 2. Kyorin University Faculty of Medicine Nursing Department)

[JP11-5] Lusiradon hydrochloride effected drug-Resistrated depression.

*Chiharu Tamagaki¹, Toshihiko Kinoshita¹ (1. Kansai Medical University)

[JP11-6] A Case report: Olanzapine and Accenapin maleate effected blephalospasm in schizophrenia.